Atlas Trials

ICIs Neoadjuvant Therapy in Resectable Non-Small-Cell Lung Cancer

Clinical trial NCT03732664 · COMPLETED

Trial details

NCT number
NCT03732664
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
High-Risk Resectable NSCLC
Start date
2018-10-01
Primary completion
2023-03-23
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.